Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$1.00 -0.07 (-6.94%)
Closing price 04:00 PM Eastern
Extended Trading
$1.02 +0.02 (+2.24%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RMTI vs. RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, and RMD

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and ResMed (RMD). These companies are all part of the "health care equipment" industry.

Rockwell Medical vs.

Rockwell Medical (NASDAQ:RMTI) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, community ranking, valuation and earnings.

Rockwell Medical presently has a consensus target price of $4.00, indicating a potential upside of 301.73%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Rockwell Medical is more favorable than ReShape Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
ReShape Lifesciences
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Rockwell Medical has a net margin of -1.25% compared to ReShape Lifesciences' net margin of -86.36%. Rockwell Medical's return on equity of 8.55% beat ReShape Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-1.25% 8.55% 3.80%
ReShape Lifesciences -86.36%-179.83%-91.48%

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are owned by institutional investors. 3.6% of Rockwell Medical shares are owned by insiders. Comparatively, 0.0% of ReShape Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ReShape Lifesciences received 86 more outperform votes than Rockwell Medical when rated by MarketBeat users. Likewise, 66.11% of users gave ReShape Lifesciences an outperform vote while only 57.78% of users gave Rockwell Medical an outperform vote.

CompanyUnderperformOutperform
Rockwell MedicalOutperform Votes
312
57.78%
Underperform Votes
228
42.22%
ReShape LifesciencesOutperform Votes
398
66.11%
Underperform Votes
204
33.89%

Rockwell Medical has higher revenue and earnings than ReShape Lifesciences. Rockwell Medical is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$97.73M0.35-$8.44M-$0.02-49.79
ReShape Lifesciences$8.01M0.47-$11.39M-$343.02-0.01

In the previous week, Rockwell Medical and Rockwell Medical both had 2 articles in the media. ReShape Lifesciences' average media sentiment score of 0.24 beat Rockwell Medical's score of -0.08 indicating that ReShape Lifesciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ReShape Lifesciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Rockwell Medical has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500.

Summary

Rockwell Medical beats ReShape Lifesciences on 13 of the 18 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$36.57M$6.48B$5.35B$8.38B
Dividend YieldN/A2.66%5.22%4.10%
P/E Ratio-19.918.9226.8419.71
Price / Sales0.35250.95391.39116.98
Price / Cash92.7365.8538.2534.62
Price / Book1.336.466.794.50
Net Income-$8.44M$143.98M$3.23B$248.18M
7 Day Performance-1.42%3.04%4.07%1.14%
1 Month Performance-2.38%7.44%12.52%15.20%
1 Year Performance-44.68%-2.46%16.83%6.56%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
4.1224 of 5 stars
$1.00
-6.9%
$4.00
+301.7%
-40.6%$36.57M$97.73M-19.91300Analyst Revision
RSLS
ReShape Lifesciences
0.5629 of 5 stars
$6.01
-9.8%
N/A-98.1%$2.71M$8.01M-0.0250News Coverage
Earnings Report
Gap Down
ABT
Abbott Laboratories
4.8788 of 5 stars
$131.90
-1.0%
$142.59
+8.1%
+30.9%$229.49B$42.34B17.24115,000News Coverage
Positive News
ISRG
Intuitive Surgical
4.2751 of 5 stars
$561.43
+4.6%
$598.95
+6.7%
+39.3%$201.23B$8.71B87.5912,100Positive News
BSX
Boston Scientific
4.1927 of 5 stars
$102.76
-0.1%
$114.52
+11.4%
+41.3%$152.02B$17.55B82.2145,000Positive News
Options Volume
SYK
Stryker
4.9273 of 5 stars
$387.97
+1.9%
$427.05
+10.1%
+18.1%$148.08B$23.22B50.0051,000Positive News
MDT
Medtronic
4.4819 of 5 stars
$85.70
+2.7%
$96.14
+12.2%
+1.9%$109.91B$33.20B26.0595,000Trending News
Earnings Report
Dividend Increase
Analyst Forecast
Options Volume
BDX
Becton, Dickinson and Company
4.9818 of 5 stars
$175.22
+4.8%
$231.44
+32.1%
-25.5%$50.22B$20.87B29.1177,000Positive News
High Trading Volume
EW
Edwards Lifesciences
3.8882 of 5 stars
$74.65
+1.3%
$79.45
+6.4%
-13.3%$43.88B$5.52B10.7117,300Positive News
IDXX
IDEXX Laboratories
3.4005 of 5 stars
$509.53
+3.6%
$524.75
+3.0%
-2.4%$40.98B$3.93B47.7510,800Positive News
Analyst Forecast
RMD
ResMed
4.1302 of 5 stars
$247.71
+1.1%
$258.83
+4.5%
+13.4%$36.32B$5.02B29.258,160News Coverage
Positive News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners